The battle of the sexes for stroke therapy: Female- versus male-derived stem cells

CNS and Neurological Disorders - Drug Targets

Volumn 12, Issue 3, 2013, Pages 405-412

  Kaneko, Yuji ^a   Pabon, Mibel M ^a   Dailey, Travis ^a   Weinbren, Nathan L ^a   Rizzi, Jessica ^a   Tamboli, Cyrus ^a   Vasconcellos, Julianne ^a   Kuzmin Nichols, Nicole ^b   Sanberg, Paul R ^a   Eve, David J ^a   Tajiri, Naoki ^a   Borlongan, Cesar V ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b Saneron CCEL Therapeutics Inc   (United States)

Author keywords

Autologous; Ischemic stroke; Menstrual blood; Regenerative; Sertoli cells

Indexed keywords

CASPASE 3; CASPASE 9; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; INTERLEUKIN 6; NEUROTROPHIC FACTOR; SOMATOMEDIN; TESTOSTERONE; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR SOX9; TUMOR NECROSIS FACTOR; TYROSINE 3 MONOOXYGENASE; VASCULOTROPIN;

ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CELL SURVIVAL; CELL THERAPY; CEREBROVASCULAR ACCIDENT; CLONOGENESIS; CRYOPRESERVATION; ENDOMETRIUM CELL; GENE EXPRESSION; HUMAN; INCIDENCE; INFLAMMATION; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PERSONALIZED MEDICINE; PROTEIN EXPRESSION; SERTOLI CELL; STEM CELL TRANSPLANTATION;

ANIMALS; BLOOD CELLS; CELL SEPARATION; CRYOPRESERVATION; FEMALE; HUMANS; MALE; MENSTRUATION; SERTOLI CELLS; STEM CELL TRANSPLANTATION; STROKE; TRANSPLANTATION, AUTOLOGOUS;

EID: 84878638407     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/1871527311312030013     Document Type: Article

References (114)

1. Gargett, C.E.; Schwab, K.E.; Zillwood, R.M.; Nguyen, H.P.; Wu, D. Isolation and culture of epithelial progenitors and mesenchymal stem cells from human endometrium. Biol. Reprod., 2009, 80, 1136-1145.
2. Xu, J.; Kenneth, D.; Kochanek, M.A.; Sherry, L.; Murphy, B.S. Deaths, final data for 2007. Natl. Vital Stat. Rep., 2010, 58, 1-134.
3. Centers for Disease Control and Prevention (CDC). (1999). Prevalence of disabilities and associated health conditions among adults, United States. M.M.W.R. Morb. Mortal Wkly Rep., 1999, 50, 120-125.
4. Richard Green, A.; Odergen, T.; Ashwood, T. Animal models of stroke: do they have value for discovering neuroprotective agents? Trends Pharmacol. Sci., 2003, 24, 402-408.
5. Chavez, J.C.; Hurko, O.; Barone, F.C.; Feuerstein, G.Z. Pharmacologic interventions for stroke: looking beyond the thrombolysis time window into the penumbra with biomarkers, not a stopwatch. Stroke, 2010, 40, e558-e563.
6. Hacke, W.; Kaste, M.; Bluhmki, E.; Brozman, M.; Dávalos, A.; Guidetti, D.; Larrue, V.; Lees, K.R.; Medeghri, Z.; Machnig, T.; Schneider, D.; von Kummer, R.; Wahlgren, N.; Toni, D.; ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N. Engl. J. Med., 2008, 359, 1317-1329.
7. Ovbiagele, B.; Nguyen-Huynh, M.N. Stroke Epidemiology: Advancing Our Understanding of Disease Mechanism and Therapy. Neurotherapeutics, 2011, 8, 319-329.
8. The National Institute of Neurological Disorders and Stroke (NINDS). rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med., 1995, 333, 1581-1587.
9. Hess, D.C.; Borlongan, C.V. Cell-based therapy in ischemic stroke. Expert Rev. Neurother., 2008, 8, 1193-1201.
10. Kleindorfer, D.; Lindsell, C.J.; Brass, L.; Koroshetz, W.; Broderick, J.P. National US estimates of recombinant tissue plasminogen activator use, ICD-9 codes substantially underestimate. Stroke, 2008, 39, 924-928.
11. Kriz J. Inflammation in ischemic brain injury, timing is important. Crit. Rev. Neurobiol., 2006, 18, 145-157.
12. Amor, S.; Puentes, F.; Baker, D.; van der Valk, P. Inflammation in neurodegenerative diseases. Immunology, 2010, 129, 154-169.
13. Emsley, C.A.; Smith, C.J.; Tyrrell, P.J.; Hopkins, S.J. Inflammation in acute ischemic stroke and its relevance to stroke critical care. Neurocrit. Care, 2008, 9, 125-138.
14. Takano, T.; Oberbeim, N.; Cotrina, M.L.; Nedergaard, M. Astrocytes and ischemic injury. Stroke, 2009, 40, S8-S12.
15. Park, D.H.; Eve, D.J.; Musso, J. 3rd; Klasko, S.K.; Cruz, E.; Borlongan, C.V.; Sanberg, P.R. Inflammation and Stem Cell Migration to the Injured Brain in Higher Organisms. Stem Cells Dev., 2009, 18, 693-701.
16. Bai, L.; Lennon, D.P.; Eaton, V.; Maier, K.; Caplan, A.I.; Miller, S.D.; Miller, R.H. Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia, 2009, 57, 1192-1203.
17. Boucherie, C.; Hermans, E. Adult stem cell therapies for neurological disorders: benefits beyond neuronal replacement? J. Neurosci. Res., 2009, 87, 1509-1521.
18. Fujiwara, Y.; Tanaka, N.; Ishida, O.; Fujimoto, Y.; Murakami, T.; Kajihara, H.; Yasunaga, Y.; Ochi, M. Intravenously injected neural progenitor cells of transgenic rats can migrate to the injured spinal cord and differentiate into neurons, astrocytes and oligodendrocytes. Neurosci. Lett., 2004, 366, 287-291.
19. Hill, W.D.; Hess, D.C.; Martin-Studdard, A.; Carothers, J.J.; Zheng, J.; Hale, D.; Maeda, M.; Fagan, S.C.; Carroll, J.E.; Conway, S.J. SDF-1 (CXCL12) is upregulated in the ischemic penumbra following stroke: association with bone marrow cell homing to injury. J. Neuropathol. Exp. Neurol., 2004, 63, 84-96.
20. Daar, A.S.; Bhatt, A.; Court, E.; Singer, P.A. Stem cell research and transplantation: Science leading ethics. Transpl. Proc., 2004, 36, 2504-2506.
21. Takagi, Y.; Nishimura, M.; Morizane, A.; Takahashi, J.; Nozaki, K.; Hayashi, J.; Hashimoto, N. Survival and differentiation of neural progenitor cells derived from embryonic cells and transplanted into ischemic brain. J. Neurosurg., 2004, 103, 304-310.
22. Ikegame, Y.; Yamashita, K.; Hayashi, S.; Mizuno, H.; Tawada, M.; You, F.; Yamada, K.; Tanaka, Y.; Egashira, Y.; Nakashima, S.; Yoshimura, S.; Iwama, T. Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy. Cytotherapy, 2011, 13, 675-685.
23. Patel, A.N.; Park, E.; Kuzman, M.; Benetti, F.; Silva, F.J.; Allickson, J.G. Multipotent Menstrual Blood Stromal Stem Cells: Isolation, Characterization and Differentiation. Cell Transplant., 2008, 17, 303-311.
24. Hida, N.; Nishiyama, N.; Miyoshi, S.; Kira, S.; Segawa, K.; Uyama, T.; Mori, T.; Miyado, K.; Ikegami, Y.; Cui, C.; Kiyono, T.; Kyo, S.; Shimizu, T.; Okano, T.; Sakamoto, M.; Ogawa, S.; Umezawa, A. Novel cardiac precursor-like cells from human menstrual blood-derived mesenchymal cells. Stem Cells, 2008, 26, 1695-1704.
25. Borlongan, C.V.; Kaneko, Y.; Maki, M.; Yu, S.J.; Ali, M.; Allickson, J.G.; Sanberg, C.D.; Kuzmin-Nichols, N.; Sanberg, P.R. Menstrual blood cells display stem cell-like phenotypic markers and exert neuroprotection following transplantation in experimental stroke. Stem Cells Dev., 2010, 19, 439-451.
26. Murphy, M.P.; Wang, H.; Patel, A.N.; Kambhampati, S.; Angle, N.; Chan, K.; Marleau, A.M.; Pyszniak, A.; Carrier, E.; Ichim, T.E.; Riordan, N.H. Allogeneic endometrial regenerative cells, an "Off the shelf solution" for critical limb ischemia? J. Transl. Med., 2008, 6, 45.
27. Wolff, E.F.; Gao, X.B.; Andrews, Z.B.; Du, H.; Elsworth, J.D.; Taylor, H.S. Endometrial stem cell transplantation restores dopamine production in a Parkinson's disease model. J. Cell Mol. Med., 2011, 15, 747-755.
28. Borlongan, C.V.; Cameron, D.F.; Saporta, S.; Sandberg, P.R. Intracerebral Transplantation of Testis-Derived SC Promotes Functional Recovery in Female Rats with 6-Hydroxydopamine- Induced Hemiparkinsonism. Exp. Neurol., 1997, 148, 388-392.
29. Saporta, S.; Cameron, D.F.; Borlongan, C.V.; Sanberg, P.R. Survival of Rat and Porcine Sertoli Cell Transplants in the Rat Striatum without Cyclosporine-A Immunosuppression. Exp. Neurol., 1997, 146, 299-304.
30. Skaletsky, H.; Kuroda-Kawaguchi, T.; Minx, P.J.; Cordum, H.S.; Hillier, L.; Brown, L.G.; Repping, S.; Pyntikova, T.; Ali, J.; Bieri, T.; Chinwalla, A.; Delehaunty, A.; Delehaunty, K.; Du, H.; Fewell, G.; Fulton, L.; Fulton, R.; Graves, T.; Hou, S.F.; Latrielle, P.; Leonard, S.; Mardis, E.; Maupin, R.; McPherson, J.; Miner, T.; Nash, W.; Nguyen, C.; Ozersky, P.; Pepin, K.; Rock, S.; Rohlfing, T.; Scott, K.; Schultz, B.; Strong, C.; Tin-Wollam, A.; Yang, S.P.; Waterston, R.H.; Wilson, R.K.; Rozen, S.; Page, D.C. The malespecific region of the human Y chromosome is a mosaic of discrete sequence classes. Nature, 2003, 423, 825-837.
31. Yamori, Y.; Nagaoka, A.; Okamoto, K. Importance of genetic factors in stroke: an evidence obtained by selective breeding of stroke-prone and stroke-resistant SHR. Circ. J., 1974, 38, 1095-1100.
32. Sudlow, C.L.; Warlow, C.P. Comparable studies of the incidence of stroke and its pathological types: Results from an international collaboration. International stroke incidence Collaboration. Stroke, 1997, 28, 491-499.
33. Bairey Merz, C.N.; Mark, S.; Boyan, B.D.; Jacobs, A.K.; Shah, P.K.; Shaw, L.J.; Taylor, D.; Marbán, E. Proceedings from the Scientific Symposium: Sex differences in cardiovascular disease and implications for therapies. J. Womens Health., 2010, 19, 1059-1072.
34. Nishino, H.; Nakajima, K.; Kumazaki, M.; Fukuda, A.; Muramatsu, K.; Deshpande, S.B.; Inubushi, T.; Morikawa, S.; Borlongan, C.V.; Sanberg, P.R. Estrogen protects against while testosterone exacerbates vulnerability of the lateral striatal artery to chemical hypoxia by 3-nitropropionic acid. Neurosci. Res., 1998, 30, 303-312.
35. Herson, P.S.; Hurn, P.D. Gender and the injured brain. Prog. Brain Res., 2010, 186, 177-187.
36. Lang, J.T.; McCullough, L.D. Pathways to ischemic neuronal cell death: are sex differences relevant? J. Transl. Med., 2008, 6, 33.
37. McCullough, L.D.; Zeng, Z.; Blizzard, K.K.; Debchoudhury, I.; Hurn, P.D. Ischemic nitric oxide and poly (ADP-ribose) polymerase-1 in cerebral ischemia: male toxicity, female protection. J. Cereb. Blood Flow Metab., 2005, 25, 502-512.
38. Yuan, M.; Siegel, C.; Zeng, Z.; Li, J.; Liu, F.; McCullough, L.D. Sex differences in the response to activation of the poly (ADPribose) polymerase pathway after experimental stroke. Exp. Neurol., 2009, 217, 210-218.
39. Renolleau, S.; Fau, S.; Goyenvalle, C.; Joly, L.M.; Chauvier, D.; Jacotot, E.; Mariani, J.; Charriaut-Marlangue, C. Specific caspase inhibitor Q-VD-OPh prevents neonatal stroke in P7 rat: a role for gender. J. Neurochem., 2007, 100, 1062-1071.
40. Liu, M.; Hurn, P.D.; Roselli, C.E.; Alkayed, N.J. Role of P450 aromatase in sex-specific astrocytic cell death. J. Cereb. Blood Flow Metab., 2007, 27, 135-141.
41. Ajmo, C.T., Jr.; Vernon, D.O.; Collier, L.; Hall, A.A.; Garbuzova- Davis, S.; Willing, A.; Pennypacker, K.R. The spleen contributes to stroke-induced neurodegeneration. J. Neurosci. Res., 2008, 86, 2227-2234.
42. Dirnagl, U.; Klehmet, J.; Braun, J.S.; Harms, H.; Meisel, C.; Ziemssen, T.; Prass, K.; Meisel, A. Stroke-induced immunodepression: experimental evidence and clinical relevance. Stroke, 2007, 38, 770-773.
43. Offner, H.; Vandenbark, A.A.; Hurn, P.D. Effect of experimental stroke on peripheral immunity: CNS ischemia induces profound immunosuppression. Neuroscience, 2009, 158, 1098-1111.
44. Zhang, B.; Subramanian, S.; Dziennis, S.; Jia, J.; Uchida, M.; Akiyoshi, K.; Migliati, E.; Lewis, AD.; Vandenbark, AA.; Offner, H.; Hurn, PD. Estradiol and G1 reduce infarct size and improve immunosuppression after experimental stroke. J. Immunol., 2010, 184, 4087-4094.
45. Chiappetta, O.; Gliozzi, M.; Siviglia, E.; Amantea, D.; Morrone, L.A.; Berliocchi, L.; Bagetta, G.; Corasaniti, M.T. Evidence to implicate early modulation of interleukin-1beta expression in the neuroprotection afforded by 17beta-estradiol in male rats undergone transient middle cerebral artery occlusion. Int. Rev. Neurobiol., 2007, 82, 357-372.
46. Li, J.; Siegel, M.; Yuan, M.; Zeng, Z.; Finnucan, L.; Persky, R.; Hurn, P.D.; McCullough, L.D. Estrogen enhances neurogenesis and behavioral recovery after stroke. J. Cereb. Blood Flow Metab., 2011, 31, 413-425.
47. Selvamani, A.; Sohrabji, F. The neurotoxic effects of estrogen on ischemic stroke in older female rats is associated with agedependent loss of insulin-like growth factor-1. J. Neurosci., 2010, 30, 6852-6861.
48. Crisostomo, P.R.; Wang, M.; Herring, C.M.; Markel, T.A.; Meldrum, K.K.; Lillemoe, K.D.; Meldrum, D.R. Gender differences in injury induced mesenchymal stem cell apoptosis and VEGF, TNF, IL-6 expression: role of the 55 kDa TNF receptor (TNFR1). J. Mol. Cell Cardiol., 2007, 42, 142-149.
49. Crisostomo, P.R.; Markel, T.A.; Wang, M.; Lahm, T.; Lillemoe, K.D.; Meldrum, D.R. In the adult mesenchymal stem cell population, source gender is a biologically relevant aspect of protective power. Surgery b., 2007, 142, 215-221.
50. Zenovich, A.G.; Panoskaltsis-Mortari, A.; Caron, G.J.; Kolb, A.G.; Fremming, R.; Nelson, W.D.; Taylor, D.A. Sex-based differences in vascular repair with bone marrow cell therapy: relevance of regulatory and Th2-type cytokines. Transplant Proc., 2008, 40, 641-643.
51. Nelson, W.D.; Zenovich, A.G.; Ott, H.C.; Stolen, C.; Caron, G.J.; Panoskaltsis-Mortari, A.; Barnes, S.A., 3rd; Xin, X.; Taylor, D.A. Sex-dependent attenuation of plaque growth after treatment with bone marrow mononuclear cells. Circ. Res., 2007, 101, 1319-1327.
52. Golat, B.T.; Cameron, D.F. Sertoli cells enhance formation of capillary-like structures in vitro. Cell Transplant., 2008, 17, 1135-1144.
53. Shamekh, R.; El-Badri, N.S.; Saporta, S.; Pascual, C.; Sanberg, P.R.; Cameron, D.F. Sertoli cells induce systemic donor-specific tolerance in xenogenic transplantation model. Cell Transplant., 2006, 15, 45-53.
54. Yuan, J.; Yu, J-X.; Ge, J. Sexual dimorphism on the neurogenic potential of rhesus monkeys mesenchymal stem cells. Biochem. Biophys. Res. Comm., 2010, 396, 394-400.
55. Waldron, J.; McCourty, A.; Lecanu, L. Aging differentially affects male and female neural stem cell neurogenic properties. Stem Cells Cloning Adv. Appl. A., 2010, 3, 119-127.
56. Waldron, J.; McCourty, A.; Lecanu, L. Neural stem cell sex dimorphism in aromatase (CYP19) expression: a basis for differential neural fate. Stem Cells Cloning Adv. Appl. b., 2010, 3, 175-182.
57. Cavaco, J.E.; Laurentino, S.S.; Barros, A.; Sousa, M.; Socorro, S. Estrogen receptors alpha and beta in human testis: both isoforms are expressed. Syst. Biol. Reprod. Med., 2009, 55, 137-144.
58. Berensztein, E.B.; Baquedano, M.S.; Gonzalez, C.R.; Saraco, N.I.; Rodriguez, J.; Ponzio, R.; Rivarola, M.A.; Belgorosky, A. Expression of aromatase, estrogen receptor alpha and beta, androgen receptor, and cytochrome P-450scc in the human early prepubertal testis. Pediatr. Res., 2006, 60, 740-744.
59. Bonagura, T.W.; Zhou, H.; Babischkin, J.S.; Pepe, G.J.; Albrecht, E.D. Expression of P-450 aromatase, estrogen receptor α and β, and α-inhibin in the fetal baboon testis after estrogen suppression during the second half of gestation. Endocrine, 2011, 39, 75-82.
60. Critchley, H.O.; Brenner, R.M.; Henderson, T.A.; Williams, K.; Nayak, N.R.; Slayden, O.D.; Millar, M.R.; Saunders, P.T. Estrogen receptor beta, but not estrogen receptor alpha, is present in the vascular endothelium of the human and nonhuman primate endometrium. J. Clin. Endocrinol. Metab., 2001, 86, 1370-1378.
61. Waldron, J.; Lecanu, L. Age and sex differences in neural stem cell transplantation: a descriptive study rats. Stem Cells Cloning Adv. Appl., 2011, 24, 25-37.
62. Lecanu, L. Sex, the underestimated potential determining factor in brain tissue repair strategy. Stem Cells Dev., 2011, 20, 2031-2035.
63. Prianishnikov, V.A. On the concept of stem cell and a model of functional-morphological structure of the endometrium. Contraception, 1978, 18, 213-223.
64. Padykula, H.A. Regeneration in the primate uterus, the role of stem cells. Ann. NY Acad. Sci., 1991, 622, 47-52.
65. Meng, X.; Ichim, T.E.; Zhong, J.; Rogers, A.; Yin, Z.; Jackson, J.; Wang, H.; Ge, W.; Bogin, V.; Chan, K.W.; Thébaud, B.; Riordan, N.H. Endometrial regenerative cells: a novel stem cell population. J. Transl. Med., 2007, 5, 57.
66. Allickson, J.G.; Sanchez, A.; Yeflmenko, N.; Borlongan, C.V.; Sanberg, P.R. Recent Studies Assessing the Proliferative Capability of a Novel Adult Stem Cell Identified in Menstrual Blood. Open Stem Cell J., 2011, 3, 4-10.
67. Cui, C.H.; Uyama, T.; Miyado, K.; Terai, M.; Kyo, S.; Kiyono, T.; Umezawa, A. Menstrual blood-derived cells confer human dystrophin expression in the murine model of Duchenne muscular dystrophy via cell fusion and myogenic transdifferentiation. Mol. Biol. Cell, 2007, 18, 1586-1594.
68. Chan, R.W.; Schwab, K.E.; Gargett, C.E. Clonogenicity of human endometrial epithelial and stromal cells. Biol. Reprod., 2004, 70, 1738-1750.
69. Griswold, M.D. The central role of Sertoli cells in spermatogenesis. Semin. Cell Dev. Biol., 1998, 9, 411-416.
70. Emerich, D.F.; Hemendinger, R.; Halberstadt, C.R. The Testicular- Derived Sertoli Cell: Cellular Immunoscience to Enable Transplantation. Cell Transplant., 2003, 12, 335-349.
71. Rodriguez, A.I.; Willing, A.E.; Saporta, S.; Cameron, D.F.; Sanburg, P.R. Effects of sertoli cell transplants in a 3- nitropropionic acid model of early Huntington's disease: A preliminary study. Neurotox. Res., 2003, 5, 443-450.
72. Selawry, H.P.; Cameron, D.F. Sertoli cell-enriched fractions in successful islet cell transplantation. Cell Transplant., 1993, 2, 123-129.
73. Shamekh, R.; Newcomb, J.; Mallery, J.; Cassady, C.J.; Saporta, S.; Cameron, D.F. Survival of rat or mouse ventral mesencephalon neurons after co-transplantation with rat Sertoli cells in the mouse striatum. Cell Transplant., 2005, 14, 551-564.
74. Flokman, J.; Shing, Y. Angiogenesis. J. Biol. Chem., 1992, 267, 10931-10934.
75. Griswold, M.D. Protein secretion by Sertoli cells. In: Russell, L.D.; Griswold, M.D., Eds. General considerations. In The Sertoli Cell Cache River Press., Clearwater, 1993, pp. 195-200.
76. Niederberger, C.S.; Shubhada, S.; Kim, S.J.; Lamb, D.J. Paracrine factors and the regulation of spermatogenesis. World J. Urol., 1993, 11, 120-128.
77. Nissen, N.N.; Polverini, P.J.; Koch, A.E.; Volin, M.V.; Gamelli, R.L.; DiPietro, L.A. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am. J. Pathol., 1998, 152, 1445-1452.
78. Skinner, M. Sertoli cell secreted regulatory factors. In: Skinner, M.; Griswold, M., eds. Sertoli cell biology. Elsevier Academic Press., San Diego, 2005, pp. 95-120.
79. Skinner, M.K. Secretion of growth factors and other regulatory factors. In: Russell, L.D.; Griswold, M.D., Eds. General considerations. In The Sertoli Cell Cache River Press., Clearwater, 2003, pp. 237-247.
80. Bellgrau, D.; Gold, D.; Selawry, H.; Moore, J.; Franzusoff, A.; Duke, R.C. A role for CD-95 ligand in preventing graft rejection. Nature, 1995, 377, 630-632.
81. French, L.E.; Hahne, M.; Viard, I.; Radlgruber, G.; Zanone, R.; Becker, K.; Müller, C.; Tschopp, J. Fas and Fas ligand in embryos and adult mice: Ligand expression in several immuneprivileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J. Cell Biol., 1996, 133, 335-343.
82. Sanberg, P.R.; Saporta, S.; Borlongan, C.V.; Othberg, A.L.; Allen, R.C.; Cameron, D.F. The testis-derived cultured Sertoli cell as a natural Fas-L secreting cell for immunosuppressive cellular therapy. Cell Transplant., 1997, 62, 191-193.
83. Kojima, Y.; Hayashi, Y.; Mizuno, K.; Sasaki, S.; Fukui, Y.; Koopman, P.; Morohashi, K.; Kohri, K. Up-regulation of SOX9 in human sex-determining region on the Y chromosome (SRY)- negative XX males. Clin. Endocrinol., 2008, 68, 791-799.
84. Frojdman, K.; Harley, V.R.; Pelliniemi, L.J. Sox9 protein in rat Sertoli cells is age and stage dependent. Histochem. Cell Biol., 2000,113, 31-36.
85. Kent, J.; Wheatley, S.C.; Andrews, J.E.; Sinclair, A.H.; Koopman, P. A male-specific role for SOX9 in vertebrate sex determination. Development, 1996, 122, 2813-2822.
86. Morais da Silva, S.; Hacker, A.; Harley, V.; Goodfellow, P.; Swain, A.; Lovell-Badge, R. Sox9 expression during gonadal development implies a conserved role for the gene in testis differentiation in mammals and birds. Nat. Genet., 1996, 14, 62-68.
87. Bockers, T.M.; Nieschlag, E.; Kreutz, M.R.; Bergmann, M. Localization of follicle-stimulating hormone (FSH) immunoreactivity and hormone receptor mRNA in testicular tissue of infertile men. Cell Tissue Res., 1994, 278, 595-600.
88. Hemendinger, R.A.; Gores, P.; Blacksten, L.; Harley, V.; Halberstadt, C. Identification of a specific Sertoli cell marker, Sox9, for use in transplantation. Cell Transplant., 2002, 11, 499-505.
89. Davidoff, M.S.; Middendorff, R.; Koeva, Y.; Pusch, W.; Jezek, D.; Muller, D. Glial cell line-derived neurotrophic factor (GDNF) and its receptors GFRalpha-1 and GFRal pha-2 in the human testis. Ital. J. Anat. Embryol., 2001, 106, 173-180.
90. Hofmann, M.C. Gdnf signaling pathways within the mammalian spermatogonial stem cell niche. Mol. Cell Endocrinol., 2008, 288, 95-103.
91. Dufour, J.M.; Rajotte, R.V.; Korbutt, G.S.; Emerich, D.F. Harnessing the immunomodulatory properties of sertoli cells to enable xenotransplantation in type I diabetes. Immunol. Invest., 2003, 32, 275-297.
92. Cho, N.H.; Park, Y.K.; Kim, Y.T.; Yang, H.; Kim, S.K. Lifetime expression of stem cell markers in the uterine endometrium. Fertil. Steril., 2004, 81, 403-407.
93. Zhong, Z.; Patel, A.N.; Ichim, T.E.; Riordan, N.H.; Wang, H.; Min, W.P.; Woods, E.J.; Reid, M.; Mansilla, E.; Marin, G.H.; Drago, H.; Murphy, M.P.; Minev, B. Feasibility investigation of allogeneic endometrial regenerative cells. J. Transl. Med., 2009, 7, 15.
94. Fan, X.; Krieg, S.; Kuo, C.J.; Wiegand, S.J.; Rabinovitch, M.; Druzin, M.L.; Brenner, R.M.; Giudice, L.C.; Nayak, N.R. VEGF blockade inhibits angiogenesis and reepithelialization of endometrium. FASEB J., 2008, 22, 3571-3580.
95. Drago, H.; Marin, G.H.; Sturla, F.; Roque, G.; Mártire, K.; Díaz Aquino, V.; Lamonega, R.; Gardiner, C.; Ichim, T.; Riordan, N.; Raimondi, J.C.; Bossi, S.; Samadikuchaksaraei, A.; van Leeuwen, M.; Tau, J.M.; Núñez, L.; Larsen, G.; Spretz, R.; Mansilla, E. The next generation of burns treatment, intelligent films and matrix, controlled enzymatic debridement, and adult stem cells. Transplant Proc., 2010, 42, 345-349.
96. Sanberg, P.R.; Borlongan, C.V.; Saporta, S.; Cameron, D.F. Sertoli cells: An alternative cell source for neural transplantation in Parkinson's disease. Exper. Neurol., 1995, 135, 169.
97. Sanberg, P.R.; Borlongan, C.V.; Saporta, S.; Cameron, D.F. Testisderived Sertoli cells survive and provide localized immunoprotection for xenografts in rat brain. Nat. Biotechnol., 1996, 14, 1692-1695.
98. Lau, H.T.; Yu, M.; Fontana, A.; Stoeckert, C.J Jr. Prevention of islet rejection with engineered myoblast expressing FasL in mice. Science, 1996, 273, 109-112.
99. Sanberg, P.R.; Othberg, A.I.; Borlongan, C.V.; Saporta, S.; Anton, A.; Freeman, T.B.; Cahill, D.W.; Allen, R.C.; Cameron, D.F. Transplantation of testis-derived Sertoli cells into the mammalian brain. Tranplant. Proc., 1997, 29, 1926-1928.
100. Griffith, T.S.; Brunner, T.; Fletcher, S.M.; Green, D.R.; Ferguson, T.A. FAS ligand-induced apoptosis as a mechanism of immune privilege. Science, 1995, 270, 1189-1192.
101. Gnessi, L.A.; Emidi, E.A.; Jannini, E.; Carosa, E.; Maroder, M.; Arizzi, M.; Ulisse, S.; Spera, G. Testicular development involves the spatiotemporal control of PDGFs and PDGF receptors gene expression and action. J. Cell Biol., 1995, 131, 1105-1121.
102. Uccelli, A.; Moretta, L.; Pistoia, V. Immunoregulatory function of mesenchymal stem cells. Eur. J. Immunol., 2006, 36, 2566-2573.
103. Zhang, M.J.; Liu, B.; Xia, W.; Sun, Z.Y.; Lu, K.H. Could cells from menstrual blood be a new source for cell-based therapies? Med. Hypotheses, 2009, 72, 252-254.
104. Nurmio, M.; Keros, V.; Lähteenmäki, P.; Salmi, T.; Kallajoki, M.; Jahnukainen, K. Effect of childhood acute lymphoblastic leukemia therapy on spermatogonia populations and future fertility. J. Clin. Endocrinol. Metab., 2009, 94, 2119-2122.
105. Halley, K.; Dyson, E.L.; Kaur, G.; Mital, P.; Uong, P.M.; Dass, B.; Crowell, S.N.; Dufour, J.M. Delivery of a therapeutic protein by immune-privileged Sertoli cells. Cell Transplant., 2010, 19, 1645-1657.
106. Izadyar, F.; Spierenberg, G.T.; Creemers, L.B.; den Ouden, K.; de Rooij, D.G. Isolation and purification of type A spermatogonia from the bovine testis. Reproduction, 2002, 124, 85-94.
107. Ryser, S.; Glauser, D.; Vigier, M.; Zhang, Y.Q.; Tachini, P.; Schlegel, W.; Durand, P.; Irminger-Finger, I. Gene expression profiling of rat spermatogonial and Sertoli cells reveals signaling pathways from stem cells to niche and testicular cancer cells to surrounding stroma. BMC Genomics, 2011, 12, 29.
108. Brinster, C.J.; Ryu, B.Y.; Avarbock, M.R.; Karagenc, L.; Brinster, R.L.; Orwig, K.E. Restoration of fertility by germ cell transplantation requires effective recipient preparation. Biol. Reprod., 2003, 69, 412-420.
109. Ogawa, T.; Dobrinski, I.; Brinster, R.L. Recipient preparation is critical for spermatogonial transplantation in the rat. Tissue Cell., 1999, 31, 461-472.
110. Shinohara, T.; Orwig, K.E.; Avarbock, M.R.; Brinster, R.L. Remodeling of the postnatal mouse testis is accompanied by dramatic changes in stem cell number and niche accessibility. Proc. Natl. Acad, Sci. USA, 2001, 98, 6186-6191.
111. McLean, D.J.; Friel, P.J.; Johnston, D.S.; Griswold, M.D. Characterization of spermatogonial stem cell maturation and differentiation in neonatal mice. Biol. Reprod., 2003, 69, 2085-2091.
112. Yoshida, S.; Sukeno, M.; Nakagawa, K.; Ohbo, K.; Nagamatsu, G.; Suda, T.; Nabeshima, Y. The first round of mouse spermatogenesis is a distinctive program that lacks the self-renewing spermatogonia stage. Development, 2006, 133, 1495-1505.
113. Nakagawa, T.; Nabeshima, Y.; Yoshida, S. Functional identification of the actual and potential stem cell compartments in mouse spermatogenesis. Dev. Cell., 2007, 12, 195-206.
114. Gunsalus, G.L.; Larrea, F.; Musto, N.A.; Becker, P.R.; Mather, J.P.; Bardin, C.W. Androgen binding protein as a marker for sertoli cell function. J. Steroid Biochem., 1981, 15, 99-106.